Spain· ES:114963001IP
BRIMICA GENUAIR 340 MICROGRAMOS/12 MICROGRAMOS POLVO PARA INHALACION
A medicinal product containing aclidinio + formoterol, registered in Spain by Covis Pharma Europe B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- aclidinio + formoterol
- Manufacturer
- Covis Pharma Europe B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo77018160EUR 70.25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aclidinio + formoterol in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBRIMICA GENUAIRCovis Pharma Europe B.V., Amsterdam
- SwedenBrimica Genuair 340 mikrogram/12 mikrogram InhalationspulverCovis Pharma Europe B.V.
- FinlandBrimica GenuairCOVIS PHARMA EUROPE B.V.
- PolandBrimica GenuairCovis Pharma Europe B.V.
- IcelandBrimica GenuairCovis Pharma Europe B.V.
- NetherlandsBrimica Genuair 340 microgram/12 microgram, inhalatiepoederCovis Pharma Europe B.V.
- United KingdomAclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhalerColorama Pharmaceuticals Ltd
- United StatesDUAKLIR PRESSAIRCovis Pharma US, Inc
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Brimica Genuair, Duaklir Genuair
- Liechtenstein · Brimica Genuair, Duaklir Genuair
- Norway · Brimica Genuair, Duaklir Genuair
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/882a3f28-6bab-47bd-9edd-e967ea1b8a8b GET /v1/drugs/882a3f28-6bab-47bd-9edd-e967ea1b8a8b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1773935534000}",
"nregistro": "114963001IP",
"substance": "aclidinio + formoterol"
}See everything about aclidinio + formoterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.